Clinical Benefit of Antiviral Agents for Hepatocellular Carcinoma Patients With Low Preoperative HBV-DNA Loads Undergoing Curative Resection: A Meta-Analysis
Open Access
- 19 February 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Abstract
Background and Aims: The clinical benefit of adjuvant antiviral therapy after curative therapy for HCC in patients with high preoperative HBV-DNA loads has been studied widely but that in patients with low preoperative HBV-DNA loads remains controversial. The purpose of this study was to determine the effect of antiviral treatment prophylaxis on HBV reactivation, overall survival (OS), and postoperative liver function in patients with low preoperative HBV-DNA levels undergoing curative resection.Methods: A meta-analysis was conducted by searching Web of Science, PubMed, Embase, and Cochrane Library until May 2020. We used REVMAN for data analysis and completed the study under the PRISMA guidelines.Results: Three randomized trials and seven cohort studies, comprising of 1,131 individuals, were included in the meta-analysis. Antiviral treatment significantly reduced the rate of HBV reactivation after curative treatment of HCC, with a pooled risk ratio of 0.12 (95% c.i. 0.07 to 0.21; P < 0.00001). The trials were consistently favorable for the antiviral group, with a pooled hazard ratio of 0.52 (95% c.i. 0.37 to 0.74; P = 0.0002) in respect of OS rate. However, by pooling the data from studies that reported ALT on the 30th day postoperatively, the result didn’t reach statistical significance (mean difference −4.38, 95% c.i. −13.83 to 5.07; P = 0.36). The I² values of the heterogeneity test for the above three comparisons are zero.Conclusion: Antiviral therapy during curative resection is effective in reducing HBV reactivation and improving OS rate in HCC patients with low viral load.Keywords
Funding Information
- National Natural Science Foundation of China
- Taishan Scholar Project of Shandong Province
This publication has 33 references indexed in Scilit:
- Posthepatectomy HBV Reactivation in Hepatitis B–Related Hepatocellular Carcinoma Influences Postoperative Survival in Patients With Preoperative Low HBV-DNA LevelsAnnals of Surgery, 2013
- Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinomaLiver International, 2013
- Antiviral therapy decreases viral reactivation in patients with hepatitis B virus–related hepatocellular carcinoma undergoing hepatectomy: a randomized controlled trialJournal of Viral Hepatitis, 2012
- High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: A prospective cohort studyEuropean Journal of Surgical Oncology, 2012
- High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV LoadGastroenterology, 2012
- Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2011
- Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinomaJournal of Hepatology, 2009
- Hepatitis B Virus-Related Cirrhosis: Natural History and TreatmentSeminars in Liver Disease, 2006
- Liver Resection for Hepatocellular Carcinoma on CirrhosisAnnals of Surgery, 2003
- Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis BHepatology, 2000